Related Experiment Video
Updated: Mar 18, 2026
13:08
Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
19.5K
Rare coagulation disorders: fibrinogen, factor VII and factor XIII
P de Moerloose1, J-F Schved2, D Nugent3
1Division of Angiology and Haemostasis, University Hospitals and Faculty of Medicine, Geneva, Switzerland.
Summary
Rare coagulation disorders (RCDs) are uncommon bleeding conditions. This review details fibrinogen, factor VII, and factor XIII deficiencies, highlighting their unique aspects within hemostasis.
Area of Science:
- Hematology
- Coagulation Science
- Rare Diseases
Background:
- Rare coagulation disorders (RCDs) encompass inherited deficiencies affecting various clotting factors.
- Understanding RCDs is crucial for a comprehensive grasp of hemostasis, despite their low prevalence.
- Each RCD presents unique characteristics despite shared features.
Purpose of the Study:
- To review and elucidate the specific features of fibrinogen, factor VII, and factor XIII deficiencies.
- To enhance understanding of these three distinct RCDs within the broader context of hemostasis.
Main Methods:
- Literature review focusing on inherited deficiencies of fibrinogen, factor VII, and factor XIII.
- Synthesis of current knowledge on the pathophysiology, clinical presentation, and management of selected RCDs.
Main Results:
- Fibrinogen deficiency impacts clot formation and stability.
- Factor VII deficiency is associated with variable bleeding, often presenting after surgery or trauma.
- Factor XIII deficiency leads to severe bleeding due to impaired clot stabilization.
Conclusions:
- Fibrinogen, factor VII, and factor XIII deficiencies are distinct RCDs with unique hemostatic implications.
- Detailed knowledge of these specific RCDs is essential for accurate diagnosis and effective management.
- Further research into RCDs contributes to a deeper understanding of the complex hemostasis system.
Related Concept Videos
01:24Disorders of Hemostasis
2.7K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.7K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.3K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
14.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
14.8K
01:09Coagulation
11.7K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
11.7K
01:06Coagulation
1.6K
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.6K
01:29Venous Thrombosis III: Interprofessional Care
454
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
454